Literature DB >> 12114687

Monoclonal Antibodies Recognizing Normal and Neoplastic Human Adrenal Cortex.

Carin Backlin, Claes Juhlin, Lars Grimelius, Kristina Wiberg, Per Heilman, Goran Akerstrom, Jonas Rastad.   

Abstract

Four monoclonal antibodies (MAb) were generated by immunization of mice with dispersed cells from normal human adrenal gland (Na) and adrenocortical adenoma causing cortisol excess (Ac). Immunohistochemically reacted cryosections revealed differential labeling of the normal cortical parenchyma, and immunofluorescence on dispersed cells displayed that Ac5 alone labeled the cell surface. Immunoprecipitation demonstrated that the antibodies recognized apparently different structures of 51-88 kDa. Immunohistochemical examination of several normal human tissues substantiated restricted reactivity, especially for the Na2 and Na7 antibodies, and that the adrenal medulla was not stained by any of the antibodies. The antibodies recognized the vast majority of the parenchymal cells of cortical adenomas (n = 21). Each antibody also reacted with all adrenocortical carcinomas (n = 17), and the staining generally was most intense and extensive with Na7. Analysis of other pathological human tissues revealed highly restricted reactivity for the Na2 antibody. Na2 and Na5 failed to stain 17 renal cell carcinomas. None of the antibodies recognized pheochromocytomas. These antibodies may lead to improved histological recognition and characterization of human adrenal lesions.

Entities:  

Year:  1995        PMID: 12114687     DOI: 10.1007/bf02914986

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  31 in total

1.  Monoclonal anti-parathyroid antibodies interfering with a Ca2+-sensor of human parathyroid cells.

Authors:  C Juhlin; H Johansson; R Holmdahl; E Gylfe; R Larsson; J Rastad; G Akerström; L Klareskog
Journal:  Biochem Biophys Res Commun       Date:  1987-03-13       Impact factor: 3.575

2.  Immunocytochemical differential diagnosis of adrenocortical neoplasms using the monoclonal antibody D11.

Authors:  S Schröder; A Niendorf; E Achilles; M Dietel; B C Padberg; U Beisiegel; H Dralle; M Bressel; G Klöppel
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

3.  Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1.

Authors:  B Skogseid; C Larsson; P G Lindgren; E Kvanta; J Rastad; E Theodorsson; L Wide; E Wilander; K Oberg
Journal:  J Clin Endocrinol Metab       Date:  1992-07       Impact factor: 5.958

4.  Monoclonal antibodies raised against mid-gut carcinoid tumor cells.

Authors:  C Juhlin; V Papanicolaou; K Backlin; L Klareskog; E Wilander; G Akerström; K Oberg; J Rastad
Journal:  World J Surg       Date:  1990 May-Jun       Impact factor: 3.352

5.  Immunohistochemical study of cytochrome P-450 11 beta-hydroxylase in human adrenal cortex with mineralo- and glucocorticoid excess.

Authors:  H Sasano; M Okamoto; N Sasano
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988

6.  Suprarenal mass and its differential diagnosis.

Authors:  J L Siekavizza; M E Bernardino; N A Samaan
Journal:  Urology       Date:  1981-12       Impact factor: 2.649

7.  Adrenocortical carcinoma. An immunohistochemical comparison with renal cell carcinoma.

Authors:  M R Wick; D L Cherwitz; R C McGlennen; L P Dehner
Journal:  Am J Pathol       Date:  1986-02       Impact factor: 4.307

8.  Hyperparathyroidism is associated with reduced expression of a parathyroid calcium receptor mechanism defined by monoclonal antiparathyroid antibodies.

Authors:  C Juhlin; L Klareskog; P Nygren; S Ljunghall; E Gylfe; J Rastad; G Akerström
Journal:  Endocrinology       Date:  1988-06       Impact factor: 4.736

9.  Apolipoprotein E-binding proteins isolated from dog and human liver.

Authors:  U Beisiegel; W Weber; J R Havinga; G Ihrke; D Y Hui; M E Wernette-Hammond; C W Turck; T L Innerarity; R W Mahley
Journal:  Arteriosclerosis       Date:  1988 May-Jun

10.  Clinical and biochemical effects in vivo of monoclonal antitumor antibody in Verner-Morrison's syndrome.

Authors:  C Juhlin; V Papanicolaou; H Arnberg; L Klareskog; L E Lörelius; J Rastad; K Oberg; G Akerström
Journal:  Cancer       Date:  1994-03-01       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.